With over five years of experience in the health and wellness industry, David Uhalley is a passionate advocate for plant-based medicines and their role in enhancing human well-being. He is the Operations Manager at Global Cannabinoid Research Center / California Nanobles Corporation, a future leader in advanced nutraceuticals that utilizes plant-based extracts, essential oils, nanotechnology, and liposomal formulations to deliver superior quality goods for humans. GCRC/Nanobles has Phytomend and Phytomend 'Aina Love' both in advanced R&D headed towards production; A product line that's medicine for plants and Mother Earth . David's extensive background spans multiple domains, such as healthcare, IT, advertising, generative AI, and robotics, demonstrating his hands-on approach and commitment to innovation. He is the founder and CEO of MyRobot, a real-time communications company that holds valuable intellectual property in automation and connectivity systems and methods. He is also the founder and CEO of LivingAds, a digital marketing venture with a patent-pending relating to triggering live media streams via dynamic display objects.David's "Medicinal Plants" certification from Cornell University's online program underscores his dedication to integrating traditional knowledge with contemporary health solutions, covering various topics from historical applications to mental health, pain relief, immunity boosting, and cancer prevention and treatment. David knowledge of the endocannabinoid system was spurred by Cornell's course and his involvement with the Global Cannabinoid Research Center. David Uhalley is a visionary figure capable of bridging the gap between ancient wisdom and modern innovation, particularly in the evolving field of plant medicine and endocannabinoid research.